Molecular mechanisms of interplay between RORγ/RORγT receptors and cyclin-dependent kinase inhibitor (AT7519). Analysis of tissue-specific interaction and activation of Th17 lymphocytes.
2019/35/N/NZ7/01618
Keywords
Descriptors
- NZ7_015: Toksykologia
- NZ7_012: Prewencja chorób człowieka
- NZ2_006: Immunogenetyka
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Instytut Biologii Medycznej PAN
Voivodeship: łódzkie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 18 – announced on 2019-09-16
- Amount awarded
- 139 920 PLN
- Project start date
- 2020-07-02
- Project end date
- 2024-07-01
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Anti-hepatocellular carcinoma activity of the cyclin-dependent kinase inhibitor AT7519
- Authors:
- Kaja Karaś, Iwona Karwaciak, Katarzyna Chałaśkiewicz, Anna Sałkowska, Joanna Pastwińska, Rafał A. Bachorz, Marcin Ratajewski
- Academic press:
- Biomedicine & Pharmacotherapy (year: 2023, volume: 164, pages: 115002), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.biopha.2023.115002 – link to the publication